It is possible that RB1 inactivation in these samples plays a noncanonical role outside of E2F-mediated cell-cycle control, as has been suggested for other cancer types that exhibit acquired RB1 alterations later in disease progression (43). This evidence concerns the gene RB1 and cancer.